Tandem Diabetes Care (TNDM) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.90% |
| Dec 31, 2025 | 0.74% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | -5.03% |
| Mar 31, 2025 | -4.70% |
| Dec 31, 2024 | 1.04% |
| Sep 30, 2024 | 2.16% |
| Jun 30, 2024 | -0.38% |
| Mar 31, 2024 | -1.22% |
| Dec 31, 2023 | 1.36% |
| Sep 30, 2023 | -0.71% |
| Jun 30, 2023 | -0.78% |
| Mar 31, 2023 | -9.37% |
| Dec 31, 2022 | 0.50% |
| Sep 30, 2022 | 1.06% |
| Jun 30, 2022 | 2.10% |
| Mar 31, 2022 | 12.17% |
| Dec 31, 2021 | 6.45% |
| Sep 30, 2021 | 6.92% |
| Jun 30, 2021 | 5.43% |
| Mar 31, 2021 | 5.28% |
| Dec 31, 2020 | 6.45% |
| Sep 30, 2020 | 9.21% |
| Jun 30, 2020 | 79.49% |
| Mar 31, 2020 | 5.28% |
| Dec 31, 2019 | 11.43% |
| Sep 30, 2019 | 14.73% |
| Jun 30, 2019 | 18.81% |
| Mar 31, 2019 | 4.07% |
| Dec 31, 2018 | 13.59% |
| Sep 30, 2018 | 14.94% |
| Jun 30, 2018 | 9.19% |
| Mar 31, 2018 | 51.76% |
| Dec 31, 2017 | 8.38% |
| Sep 30, 2017 | -10.72% |
| Jun 30, 2017 | -12.57% |
| Mar 31, 2017 | 0.29% |
| Dec 31, 2016 | 24.42% |
| Sep 30, 2016 | -17.27% |
| Jun 30, 2016 | -9.49% |
| Mar 31, 2016 | -3.27% |
| Dec 31, 2015 | -2.95% |
| Sep 30, 2015 | -9.07% |
| Jun 30, 2015 | -8.89% |
| Mar 31, 2015 | 45.71% |
| Dec 31, 2014 | -8.67% |
| Sep 30, 2014 | -10.35% |
| Jun 30, 2014 | -8.69% |
| Mar 31, 2014 | -12.22% |